Skip to main content
Top
Published in: Cancer Causes & Control 4/2002

01-05-2002

Prospective study of IGF-I, IGF-binding proteins, and breast cancer risk, in Northern and Southern Sweden

Authors: Rudolf Kaaks, Eva Lundin, Jonas Manjer, Sabina Rinaldi, Carine Biessy, Stefan Söderberg, Per Lenner, Lars Janzon, Elio Riboli, Göran Berglund, Göran Hallmans

Published in: Cancer Causes & Control | Issue 4/2002

Login to get access
Metadata
Title
Prospective study of IGF-I, IGF-binding proteins, and breast cancer risk, in Northern and Southern Sweden
Authors
Rudolf Kaaks
Eva Lundin
Jonas Manjer
Sabina Rinaldi
Carine Biessy
Stefan Söderberg
Per Lenner
Lars Janzon
Elio Riboli
Göran Berglund
Göran Hallmans
Publication date
01-05-2002
Publisher
Kluwer Academic Publishers
Published in
Cancer Causes & Control / Issue 4/2002
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1023/A:1015270324325

Other articles of this Issue 4/2002

Cancer Causes & Control 4/2002 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine